Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Author:
Funder
ESMO
AstraZeneca
Celgene, Daiichi Sankyo
Eisai
Genentech
GlaxoSmithKline
Merck Sharp & Dohme
EGIS Pharmaceuticals
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/advance-article-pdf/doi/10.1093/annonc/mdz173/29001668/mdz173.pdf
Reference216 articles.
1. ECIS-European Cancer Information System. https://ecis.jrc.ec.europa.eu (25 March 2019, date last accessed).
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
3. Behavioral risk factors in breast cancer: can risk be modified?;McTiernan;Oncologist,2003
4. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database;Autier;BMJ,2010
5. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani;Lancet,2015
Cited by 1594 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phase angle as a potential tool to evaluate chronic inflammatory state and predict quality of life deterioration in women with breast cancer and obesity: A narrative review;Nutrition;2024-11
2. Evolving therapeutics and ensuing cardiotoxicities in triple-negative breast cancer;Cancer Treatment Reviews;2024-11
3. Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up;The Breast;2024-10
4. Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study;The Breast;2024-10
5. Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer;The Breast;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3